New pharmacological treatments for heart failure with reduced ejection fraction (HFrEF): A Bayesian network meta-analysis

BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) has contributed to an increasing number of deaths and readmissions over the past few decades. Despite the appearance of standard treatments, including diuretics, β-receptor blockers and angiotensin-converting enzyme inhibitor (ACEI), t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Heng, Duan, Yuting, Chen, Benfa, Zhao, Yu, Su, Weiping, Wang, Shanhua, Wu, Jiaming, Lu, Liming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004768/
https://www.ncbi.nlm.nih.gov/pubmed/32000355
http://dx.doi.org/10.1097/MD.0000000000018341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004768/
https://www.ncbi.nlm.nih.gov/pubmed/32000355
http://dx.doi.org/10.1097/MD.0000000000018341

Ejemplares similares